CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

RealTime Software Solutions Acquires Complion

RealTime Software Solutions Acquires...

What role does artificial intelligence play in the employment process?

What role does artificial...

Why AI is Used for Quality Management in Life Science

Why AI is Used for Quality Management...

Application of AI in Genetics

Application of AI in Genetics

How Artificial Intelligence Impacts Biotechnology

How Artificial Intelligence Impacts...

Akanta's Contextual Intelligence 360 to Enhance Customer Experience

Akanta's Contextual Intelligence 360...

Syneos Health's Acquisition of RxDataScience to Help Boost Product Development

Syneos Health's Acquisition of...

DNA Sequencing Evolving With Groundbreaking Technology

DNA Sequencing Evolving With...

RealTime Software Solutions Acquires Complion

RealTime Software Solutions Acquires...

What role does artificial intelligence play in the employment process?

What role does artificial...

Why AI is Used for Quality Management in Life Science

Why AI is Used for Quality Management...

Application of AI in Genetics

Application of AI in Genetics

How Artificial Intelligence Impacts Biotechnology

How Artificial Intelligence Impacts...

Akanta's Contextual Intelligence 360 to Enhance Customer Experience

Akanta's Contextual Intelligence 360...

Syneos Health's Acquisition of RxDataScience to Help Boost Product Development

Syneos Health's Acquisition of...

DNA Sequencing Evolving With Groundbreaking Technology

DNA Sequencing Evolving With...

MMIT/Evaluate to Boost Pharma Analytics After Acquisition of Panalgo

Life Sciences Review Life Sciences Review | Monday, October 25, 2021
Tweet

The acquisition results in an innovative, market-leading analytics platform that offers on-demand insights across dozens of normalized real-world evidence and market access data sets to aid in decision-making throughout the pipeline and prescription process.


FREMONT, CA: “MMIT/Evaluate and Panalgo share a vision of generating evidence and insights faster, all to help patients get timely access to lifesaving therapies. The addition of Panalgo fits perfectly into our strategy of building a best-in-breed technology and services-driven healthcare business servicing pharma, biotech and beyond,” states MMIT CEO Mike Gallup. Managed Markets Insight & Technology (MMIT) and Evaluate, a Welsh, Carson, Anderson & Stowe, and Hg portfolio company, which merged last month to form a $1.6 billion global provider of pharmaceutical commercial intelligence confirm the acquisition of Panalgo, a premier healthcare data analytics company that serves many of the world’s largest biopharmaceutical, medical device, and contract research organizations


MMIT and Evaluate hope to change the process of bringing pharmaceuticals to market with this acquisition. 


By integrating Panalgos’ flagship Instant Health Data (IHD) software, MMIT and Evaluate will provide customers with an end-to-end commercialization platform that quickly gives vital, data-driven insights, enabling life sciences professionals to make smarter decisions faster.


“The ability to quickly generate insights, inform decisions on the effectiveness and safety of new treatments, and reduce barriers to accessing care, all fulfill a huge need in the marketplace,” says Panalgo CEO Joseph Menzin, Ph.D. “With Panalgo’s best-in-class platform, MMITs expansive base of over 1,300 biopharma and payer customers, and its gold-standard formulary data, we are well-equipped to support clients from end to end.”


Jordan Menzin, CTO, will succeed Joseph Menzin as CEO of Panalgo on Nov. 1, 2021. Panalgo will continue to operate under its brand and offer cutting-edge IHD software and superior customer service.


“I’m excited to lead this next phase of Panalgo’s growth,” says Jordan Menzin. “Together, we’ll help clients solve problems by leveraging quicker, more efficient insights and, ultimately, get therapies into the hands of the patients who need them.”


Weekly Brief

loading
> <
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Proteomics 2022

    Top Vendors

    Current Issue

Read Also

Qualities to Consider when Choosing Life Sciences Business Consultants for Your Firm

How Biotech Startups can Mitigate Risks in Order to Grow Sustainably

Cellf BIO's BioShincter to Undergo Phase 1 Trail to Test Fecal Incontinence Treatment

Fulcrum Therapeutics Announces CEO Transition

An Overview of Wholesalers' Roles in Complex Supply Chains

Veeva Opening Up Integration Module for Future Opportunities and Applications

Veeva Systems To Accelerate the CRM of Life Science Businesses

The Role of Technology in Advancing Clinical Trials

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/mmitevaluate-to-boost-pharma-analytics-after-acquisition-of-panalgo-nwid-604.html